ReShape Lifesciences RSLSD 深 沪
已收盘 11-12 16:00:00 美东时间
0.00
0.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.00
- 总市值 0
- 52周最高 441000.00
- 市盈率 静 --
- 换手率 NaN.00%
- 52周最低 7.80
- 委 比 0.00%
- 总股本 0
- 历史最高 529200.00
- 量 比 0
- 振 幅 NaN.00%
- 历史最低 7.80
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Vyome Therapeutics Sets Board To Lead Reshape Lifesciences Post-Close; New Entity To Trade As Vyome Holdings Under Ticker Symbol HIND
Heavily shareholder-aligned board and management team completely replaces ReShape team as Vyome prepares for public listing on August 15, 2025Vyome Therapeutics, Inc., a clinical-stage healthcare company targeting
08-12 21:55
ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit
ReShape Lifesciences will host its first Lap-Band® Surgeon Summit from August 1-3, 2025, in Nashville, featuring Dr. Christine Ren-Fielding as director. The event will focus on the benefits of the Lap-Band® System, including the new 2.0 FLEX, and advancements in GLP-1 therapies. The company aims to enhance patient outcomes and expand access to these weight management tools through collaboration with leading surgeons.
07-22 12:31
'ReShape Lifesciences Granted U.S. Patent Related To An Intragastric Balloon System'
https://reshapelifesciences.gcs-web.com/news-releases/news-release-details/reshape-lifesciencesr-granted-us-patent-related-intragastric
07-08 22:26
ReShape Lifesciences Loans $200K to Vyome Therapeutics
ReShape Lifesciences ( ($RSLS) ) has shared an announcement. On June 27, 2025, ...
07-04 04:33
ReShape Lifesciences Granted U.S. Patent 12,350,179 Entitled "Intragastric Device."
The patent, related to the Company's application 18/241,151 and notice of allowance received in April, covers claims for an intragastric balloon system, comprising a swallowable capsule with a self-sealing fill valve and
07-01 20:34
ReShape Lifesciences regains Nasdaq compliance
ReShape Lifesciences (NASDAQ:RSLS) has regained compliance with Nasdaq requiring at least $2.5M in stockholders’ equity. Source: Press release More on ReShape Lifesciences ReShape Lifesciences Inc. (R...
06-27 21:53
ReShape Lifesciences Announces Strategic Headcount Reduction; Issues Update On Merger Agreement With Vyome Therapeutics And Asset Purchase Agreement With Biorad Medisys
Reduction in Force Estimated to Save Over $750K or 23.4% of Annual Payroll ExpensesAgreements Progress Toward Completion; Shareholder Meeting Scheduled for July 24, 2025IRVINE, Calif., June 26, 2025 (GLOBE NEWSWIRE) --
06-26 20:33
ReShape Lifesciences Raises Equity to Avoid Delisting
ReShape Lifesciences ( ($RSLS) ) has issued an announcement. On May 28, 2025, R...
06-19 05:56
Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Shares of RH (NYSE:RH) rose sharply in today's pre-market trading as the compan...
06-13 17:08
ReShape Lifesciences prices $2.6M public offering
ReShape Lifesciences (NASDAQ:RSLS) on Monday announced the pricing of its public offering of 1.05M shares of common stock at a public offering price of $2.50 per share for gross proceeds of about $2.6...
06-10 00:18
